Anbioton has been acquired by Elfa Medicamentos

The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.

Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.

Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.

One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.